The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Asian Joint Panel Discussion

B-cell malignancy including multiple myeloma

Sun. Oct 14, 2018 8:30 AM - 10:40 AM No.2 (Osaka International Convention Center, 5F Sub Hall)

Chairs: Junji Suzumiya (Shimane University Hospital, Innovative Cancer Center, Department Oncology・Hematology, Japan), Wichai Prayoonwiwat (Thai Society of HematologyPhramongkutklao Hospital, Thailand)

【E】

[APD-3] Status of maintenance in B-cell lymphoma management

Wonseog Kim (Samsung Medical Center, Seoul, Korea)

Prof Won-Seog Kim is a Professor of Division of Hematology-Oncology at Samsung Medical Center and in charge of malignant lymphoma service. He is working as a chairman of lymphoma working party of Korean Society of Hematology and consortium for improved survival of lymphoma (CISL). He is also one of the founding members of Asian Lymphoma study group (ALSG). He is now co-chairing of T-cell lymphoma forum.
Malignant lymphoma is Prof Kim’s area of special interest. Recently, he is much more focus on the management of T or NK/T-cell lymphomas and new compounds. He has published more than 280 peer-reviewed articles on clinical research in malignant lymphoma. His award achievements include Outstanding Research Award from Korean Society of Hematology (2010), Best Achievement in inpatient care (2006) and in Research (2007) from Samsung Medical Center, and Outstanding senior researcher award from Korean society of hematology (2016).

Abstract password authentication.
Password is written on a program and abstract book.

Password